Dichbio and DIESSE announce strategic partnership for the distribution of ESR solutions in China 

Monteriggioni, 26 January 2024 – Dichbio, a part of the original HongKe Technology biotechnology business, focused on life science and temperature control, and DIESSE Medical Equipment (Shanghai) Co., Ltd., the Chinese subsidiary of DIESSE Diagnostica Senese S.p.A. Società Benefit, a company with more than 40 years of experience in the world of laboratory diagnostics, announce that they have entered into a commercial agreement for the exclusive distribution of ESR assay solutions in the Chinese market.

The ESR line, based on modified Westergren technology, ensures analytical quality, and includes instrumentation useful for the diverse needs of laboratories. VES MATIC 5, the most highly automated instrument on the market, and also CUBE 30 TOUCH with high operational flexibility for medium-size laboratories and finally MINI CUBE for laboratories with lower work volumes.

Developed and manufactured in Italy by DIESSE, the ESR systems will be distributed in China by Dichbio, through its team of sales and marketing experts. Automation, ease of use, quality of analytical results, flexibility and reliability make the ESR line the ideal solution for performing diagnostic ESR tests while ensuring maximum flexibility in the workflow organization within the clinical laboratory.

“Dichbio is a dynamic company with a young and motivated team, and I am happy that we have established this partnership. Together we look forward to combine the DIESSE product expertise and Dichbio's skills and professional organization to provide our solutions together to Chinese labs and hospitals” states Lukas Owtscharenko, China General Manager & APAC Area Manager.

Massimiliano Boggetti, CEO of DIESSE also said: “This year it emerged even more strongly that the critical success factor lies in our modified Westergren technology. Our technology is more accurate in reporting quality diagnosis for patients than those offered by our main competitors and Chinese Laboratories will benefit of this and all the other values of our ESR solutions.”

Lashare Chen, CEO of Dichbio, expressed: “We are very pleased to establish an exclusive partnership with Diesse in China. Leveraging their outstanding technology in ESR and immune testing, we will gain more excellent opportunities and advantages to provide more reliable and higher-quality ESR automated testing solutions for Chinese customers. With the support of the Diesse team, Dichbio's solution capabilities and service scope will be further expanded and complemented. This is undoubtedly very advantageous for the overall upgrade of customers and industries in China."

The alliance between Dichbio and DIESSE makes it even easier to bring effective solutions to Chinese diagnostic laboratories, thus confirming the importance of the synergy between the two companies.